Clinical data presented at the ASCO congress, considered the most prestigious meeting of the oncology world, registered the historical success of a new drug developed against pancreatic cancer, which has the highest mortality rate. The developed experimental pill managed to destroy tumors by reducing the risk of death in advanced stage patients by 60 percent.